Literature DB >> 7754839

Effects of antioxidants on the blood-brain barrier and postischemic hyperemia.

E Tasdemiroglu1, P D Christenberry, J L Ardell, R B Chronister, A E Taylor.   

Abstract

The role of free oxygen radicals in blood-brain barrier (BBB) disruption and postischemic hyperemia was evaluated in the rabbit model of focal cerebral ischemia-reperfusion. Six groups of rabbits underwent clipping of the anterior cerebral, middle cerebral, and intracranial internal carotid arteries. Cerebral blood flow (CBF) was measured by using radiolabeled microspheres, before, during, and 15 minutes after 1-hour occlusion of these arteries. After 50 minutes of ischemia, Group 1 animals (control) received a placebo. Animals in Groups 2-4 received one of three drugs: catalase at 10 mg/kg, methimazole at 5 mg/kg, or indomethacin at 10 mg/kg. A fifth group received a tungsten-supplemented diet for 14 days before ischemia was induced, and a sixth group was sham operated. Microvascular integrity within the brain was determined by the presence or absence of Evan's Blue (EB)-albumin dye leakage across the BBB and was measured by microspectrofluorometry. In the control group during ischemia, CBF dropped to 14%, 7%, and 11% of preischemic levels in rostral, middle, and caudal sections of the brain, respectively, as characterized by extensive EB-albumin dye leakage through the BBB into the ischemic hemisphere. During early reperfusion, postischemic hyperemia was associated with an increase in CBF of 128%, 123%, and 129% of control in the rostral, middle, and caudal sections of the brain, respectively. In all treated groups and in the group receiving a tungsten-supplemented diet, BBB integrity was protected during reperfusion without inhibition of postischemic hyperemia. This study suggests that early disruption of the BBB to large molecules is mediated by free oxygen radicals, which inhibit rather than cause postischemic hyperemia.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7754839     DOI: 10.1007/BF01808631

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  33 in total

1.  Role of xanthine oxidase and neutrophils in ischemia-reperfusion injury in rabbit lung.

Authors:  W K Adkins; A E Taylor
Journal:  J Appl Physiol (1985)       Date:  1990-12

Review 2.  Endothelium-derived relaxing factors. A perspective from in vivo data.

Authors:  J J Marshall; H A Kontos
Journal:  Hypertension       Date:  1990-10       Impact factor: 10.190

3.  Effect of hypertension on blood-brain barrier. Change after restoration of blood flow in post-ischemic gerbil brains. An electronmicroscopic study.

Authors:  U Ito; K Ohno; T Yamaguchi; H Takei; H Tomita; Y Inaba
Journal:  Stroke       Date:  1980 Nov-Dec       Impact factor: 7.914

4.  The blood-brain barrier to protein tracers in focal cerebral ischemia and infarction caused by occlusion of the middle cerebral artery.

Authors:  Y Olsson; R M Crowell; I Klatzo
Journal:  Acta Neuropathol       Date:  1971       Impact factor: 17.088

5.  Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor.

Authors:  G M Rubanyi; P M Vanhoutte
Journal:  Am J Physiol       Date:  1986-05

6.  Effect of indomethacin and a free radical scavenger on cerebral blood flow and edema after cerebral artery occlusion in cats.

Authors:  H Johshita; T Asano; T Hanamura; K Takakura
Journal:  Stroke       Date:  1989-06       Impact factor: 7.914

7.  Quantitative EEG changes due to cerebral vasoconstriction. Indomethacin versus hyperventilation-induced reduction in cerebral blood flow in normal subjects.

Authors:  V Kraaier; A C Van Huffelen; G H Wieneke; H B Van der Worp; P R Bär
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1992-03

8.  Prostaglandin I2 and indomethacin prevent impairment of post-ischemic brain reperfusion in the dog.

Authors:  J M Hallenbeck; T W Furlow
Journal:  Stroke       Date:  1979 Nov-Dec       Impact factor: 7.914

9.  A novel concept on the pathogenetic mechanism underlying ischaemic brain oedema: relevance of free radicals and eicosanoids.

Authors:  T Asano; T Shigeno; H Johshita; M Usui; T Hanamura
Journal:  Acta Neurochir Suppl (Wien)       Date:  1987

10.  Effects of indomethacin on myogenic contractile activation and responses to changes in O2 and CO2 in isolated feline cerebral arteries.

Authors:  N A Norins; K Wendelberger; R G Hoffman; P A Keller; J A Madden
Journal:  J Cereb Blood Flow Metab       Date:  1992-09       Impact factor: 6.200

View more
  5 in total

1.  Effect of NXY-059 on infarct volume after transient or permanent middle cerebral artery occlusion in the rat; studies on dose, plasma concentration and therapeutic time window.

Authors:  S G Sydserff; A R Borelli; A R Green; A J Cross
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

2.  Dehydroascorbic acid, a blood-brain barrier transportable form of vitamin C, mediates potent cerebroprotection in experimental stroke.

Authors:  J Huang; D B Agus; C J Winfree; S Kiss; W J Mack; R A McTaggart; T F Choudhri; L J Kim; J Mocco; D J Pinsky; W D Fox; R J Israel; T A Boyd; D W Golde; E S Connolly
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

Review 3.  Nitrone-related therapeutics: potential of NXY-059 for the treatment of acute ischaemic stroke.

Authors:  Kirk R Maples; A Richard Green; Robert A Floyd
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

4.  Antioxidant CR-6 protects against reperfusion injury after a transient episode of focal brain ischemia in rats.

Authors:  Fernando J Pérez-Asensio; Xavier de la Rosa; Francesc Jiménez-Altayó; Roser Gorina; Emili Martínez; Angel Messeguer; Elisabet Vila; Angel Chamorro; Anna M Planas
Journal:  J Cereb Blood Flow Metab       Date:  2009-11-11       Impact factor: 6.200

5.  Erythrocytes, a New Contributor to Age-Associated Loss of Blood-Brain Barrier Integrity.

Authors:  Payam Amiri; Jonalyn DeCastro; Joshua Littig; Hsiang-Wei Lu; Chao Liu; Irina Conboy; Kiana Aran
Journal:  Adv Sci (Weinh)       Date:  2021-08-16       Impact factor: 16.806

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.